UK-headquartered company will characterise autoantibody profiles of clinical trial patients
Category: Uncategorized
J&J’s next-gen Darzalex sparks drug delivery royalties battle fkansteiner Thu, 09/24/2020 – 09:40
Gilead inks $97M charity kickbacks settlement with feds, but argues it did no wrong esagonowsky Thu, 09/24/2020 – […]
Did Gilead overpay for Immunomedics? Trodelvy answered that $21B-dollar question at ESMO: analyst aliu Thu, 09/24/2020 – 10:15
App will automatically alert users when they come into close contact with someone with the virus
UCB is seeking approval for treatment in moderate-to-severe plaque psoriasis
Phase III trial programme will evaluate nebulised ensifentrine in moderate-to-severe COPD
Regeneron and Sanofi won’t dethrone Merck in lung cancer despite strong Libtayo data: analysts arlene.weintraub Thu, 09/24/2020 – […]
Researchers have discovered a novel, second mechanism of action by the antiviral drug remdesivir against SARS-CoV-2. The research […]
